Clin2
NCT06930144Possibly a fitNot yet recruiting

Folate supplement for type 1 diabetes patients

Type 1 Diabetes Mellitus

Part of Hormones & metabolism, Immune system & allergy clinical trials.

This trial tests whether a folate supplement called 5-MTHF can help people with type 1 diabetes. It is for those diagnosed within the last 5 years who still produce some insulin. The goal is to see if the supplement can preserve remaining insulin-making cells.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
34 people
Ages
13 years to 65 years
Study type
Interventional

Who can take part

  • You have type 1 diabetes diagnosed by standard medical criteria.
  • You are between 13 and 65 years old.
  • You have had type 1 diabetes for 5 years or less.
  • Your body still makes some insulin, as shown by a simple blood test.
  • You are able and willing to check your blood sugar, keep records, attend study visits, and follow the study plan.
  • You must sign a consent form (with a parent or guardian if under 18).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07548996Recruiting· Phase 2/Phase 3
Study of oral dimethyl fumarate for type 1 diabetes

This study tests an oral capsule called dimethyl fumarate to see if it can help preserve the body’s own insulin production in adults with type 1 diabetes. It may offer a way to slow the loss of beta cells and reduce reliance on insulin.

Nanjing, Jiangsu
NCT07585994Recruiting
Probiotic supplement for long-standing type 1 diabetes

This study tests whether taking a specific probiotic (a beneficial bacteria) for 4 weeks can improve immune function and metabolism in people who have had type 1 diabetes for at least 5 years. Researchers believe this probiotic may help the body's remaining insulin-producing cells work better.

Amsterdam
NCT03228732Recruiting· Early Phase 1
Fluoxetine and/or DHEA in people with type 1 diabetes

This early-stage study tests whether the medicines fluoxetine and/or DHEA can improve health in adults with type 1 diabetes. It’s mainly looking for people without major diabetes complications or major medical problems to safely study the effects.

Baltimore, Maryland
NCT06474598Recruiting· Phase 2
Test of MTX228 for type 1 diabetes with some insulin

This study tests a new medication, MTX228, to see if it can help people with type 1 diabetes who still make some insulin. It may slow the loss of your own insulin production and improve blood sugar control.

Edmonton, Alberta
NCT07258394Recruiting· Phase 3
Study of dimethyl fumarate for preserving insulin in new-onset type 1 diabetes

This study tests the drug dimethyl fumarate (an oral medication already used for other conditions) to see if it can help people newly diagnosed with type 1 diabetes keep making their own insulin for longer. The goal is to slow down the immune attack on the pancreas.

Nanjing, Jiangsu
NCT07740109Not yet recruiting
Folate supplement for fatty liver disease

This trial tests whether a form of folic acid (5-methyltetrahydrofolate) can help people with fatty liver disease. It may improve liver health by supporting fat and sugar processing.

Tabriz

Hear when a new Type 1 Diabetes Mellitus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.